Bicycle Therapeutics (STU:50BA) Short-Term Capital Lease Obligation : €4.58 Mil (As of Mar. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Bicycle Therapeutics Short-Term Capital Lease Obligation?

Bicycle Therapeutics's Short-Term Capital Lease Obligation for the quarter that ended in Mar. 2024 was €4.58 Mil.

Bicycle Therapeutics's quarterly Short-Term Capital Lease Obligation increased from Sep. 2023 (€4.37 Mil) to Dec. 2023 (€4.47 Mil) and increased from Dec. 2023 (€4.47 Mil) to Mar. 2024 (€4.58 Mil).

Bicycle Therapeutics's annual Short-Term Capital Lease Obligation increased from Dec. 2021 (€2.11 Mil) to Dec. 2022 (€2.95 Mil) and increased from Dec. 2022 (€2.95 Mil) to Dec. 2023 (€4.47 Mil).

Bicycle Therapeutics Short-Term Capital Lease Obligation Historical Data

The historical data trend for Bicycle Therapeutics's Short-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bicycle Therapeutics Short-Term Capital Lease Obligation Chart

Bicycle Therapeutics Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Short-Term Capital Lease Obligation

Get a 7-Day Free Trial

0.58

0.69

2.11

2.95

4.47

Bicycle Therapeutics Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Short-Term Capital Lease Obligation	Get a 7-Day Free Trial															4.35	4.32	4.37	4.47	4.58

Bicycle Therapeutics Short-Term Capital Lease Obligation Explanation

Short-Term Capital Lease Obligation represents the total amount of Long-Term Capital Lease Obligation that must be paid within the next accounting period. Capital lease obligations are contractual obligations that arise from obtaining the use of property or equipment via a capital lease contract.

Bicycle Therapeutics Short-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Bicycle Therapeutics's Short-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Bicycle Therapeutics (STU:50BA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Bicycle Therapeutics PLC (STU:50BA) » Definitions » Short-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

BCYC:USA 50BA:Germany

Address

Granta Park, Great Abington, Blocks A and B, Portway Building, Cambridge, GBR, CB21 6GS

Website

https://www.bicycletherapeutics.com

Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops which stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical need. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC.

Bicycle Therapeutics (STU:50BA) Headlines

No Headlines